DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Cell CycleCell Cycle
  5. /Nucleoside AntimetabolitesNucleoside Antimetabolites
  6. /DetiviciclovirDetiviciclovir
Chemical structure of CAS 220984-26-9

Detiviciclovir

CAS No.220984-26-9
MDL No.N/A
MFC9H13N5O2
MW223.23
InChI KeyPIWJGZWZNOWIGH-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.220984-26-9
Product NameDetiviciclovir

Associated Conditions

hepatitis B virus infection
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Determination of antiviral nucleoside analogues AM365 and AM188 in perfusate and bile of the isolated perfused rat liver using HPLC.

Biomedical chromatography : BMC • Vol. 20, Issue 3 • 2006
PMID: 16078311DOI: 10.1002/bmc.554

Metabolism and disposition of the antiviral nucleoside analogue AM365 in the isolated perfused rat liver.

Current drug metabolism • Vol. 6, Issue 5 • 2005
PMID: 16248840DOI: 10.2174/138920005774330611

Documentation

Similar Products

  • Famciclovir

    CAS No.104227-87-4

  • Penciclovir

    CAS No.39809-25-1

  • Besifovir

    CAS No.441785-25-7

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact